David Joshua Bartch, Chief Executive Officer at Mydecine Innovations Group, holds 1.48M shares in Mydecine Innovations Group (Ticker: TSE:MYCO). Most recently, David Joshua Bartch Bought C$600,000 shares of Mydecine Innovations Group on Jan 12, 2024 for an estimated value of 18.48K.